One of the first signs of viral infection is body-wide aches and pain. While this type of pain usually subsides, at the extreme, viral infections can induce painful neuropathies that can last for decades.
INTRODUCTION
Among the earliest symptoms of viral infection are aches and pain, effects that are usually body-wide suggest a systemic factor as a cause. While viral infections often cause pain that persists during the course of the ensuing illness, some viral infections, and sustained antiviral responses, can cause neuropathies leading to chronic pain (Brizzi and Lyons, 2014; Rodriguez et al., 2019) . For instance, HIV and herpes viruses cause painful neuropathies that can last for decades (Hadley et al., 2016; Aziz-Donnelly and Harrison, 2017) . Surprisingly little is known about the mechanisms through which viruses can induce acute pain and/or lead to neuropathies. One potential mechanism is through the upregulation of indoleamine 2,3 deoxygenase (IDO1) and subsequent increase in kynurenine signaling.
In support of this idea, mice without the IDO1 enzyme lack hyperalgesia responses to certain viral infections (Huang et al., 2016) . Another possibility is that early defense responses to viral infection trigger pain hypersensitivity. From this perspective, an ideal candidate is type I interferons (IFNs) because these cytokines are rapidly induced in a wide variety of cells upon exposure to virus. These IFNs then act via their cognate receptors to induce signaling in target cells (Schreiber, 2017; Barrat et al., 2019) . We hypothesized that type I IFNs might act directly on peripheral nociceptors to cause pain.
A key component of the endogenous antiviral response is induction of cellular signaling that protects cells from viral infection and prevents viral replication. This is largely mediated by gene expression regulation signaling by type I IFNs. Type I IFNs alter gene expression in target cells by binding to heterodimeric transmembrane receptors composed of IFN receptor (IFNAR) 1 and 2 subunits and then engaging downstream signaling that activates transcriptional and translational programs in target cells (Levy and Darnell, 2002; Schreiber, 2017) . The canonical IFNAR signaling pathway involves activation of janus kinase (JAK) and signal transducer and activation of transcription (STAT) -mediated changes in transcription (Levy and Darnell, 2002; de Weerd and Nguyen, 2012; Stark and Darnell, 2012) . IFNAR activation also regulates translation of mRNAs through at least 3 pathways: 1) protein kinase R (PKR) driven phosphorylation of eukaryotic initiation factor 2 alpha (eIF2α) causing suppression of capdependent translation (Pindel and Sadler, 2011; Walsh et al., 2013) , 2) phosphoinositide 3 kinase (PI3K) driven activation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway augmenting translation of terminal oligopyrimidine tract (TOP) containing mRNAs (Thyrell et al., 2004; Hjortsberg et al., 2007) , and 3) activation of extracellular signal regulated kinase (ERK) and mitogen activated protein kinase interacting kinase (MNK) signaling resulting in eIF4E phosphorylation and translation of mRNAs targeted by this phosphorylation event such as IFN stimulated genes (e.g. Isg15
and Isg54), cytokines and matrix metalloproteinases (Platanias, 2005; Sen and Sarkar, 2007; Joshi et al., 2009 ). MNK-eIF4E activation is engaged by type I IFNs through the canonical IFNAR-JAK signaling pathway suggesting that STAT-mediated transcriptional changes and MNK-eIF4E-driven translation changes act in concert during the endogenous antiviral response (Joshi et al., 2009) . Therefore, type I IFNs produce a direct antiviral effect through PKR-mediated eIF2α phosphorylation to suppress translation and block viral replication and an indirect effect via activation of MNK-eIF4E-mediated translation to augment host defense strategies such as increased immune surveillance (Joshi et al., 2009; Pindel and Sadler, 2011; Munir and Berg, 2013) .
Nociceptors are tuned to detect a vast variety of immune modulators and can play a key role in host defense by responding directly to pathogenic organisms (Chiu et al., 2016; Foster et al., 2017; Pinho-Ribeiro et al., 2017) . In response to pathogens or inflammatory mediators, nociceptors change their sensitivity generating nociceptive signals that act as a warning system (Liu et al., 2012; Baral et al., 2016) . Overactivation of this system can lead to the generation of chronic pain disorders and damage to these neurons can cause neuropathic pain (Pinho-Ribeiro et al., 2017; Malcangio, 2019; Rodriguez et al., 2019) . A key pathway linking initial nociceptor activation to nociceptor hypersensitivity and potentially the development of chronic pain is engagement of translation regulation signaling (Obara and Hunt, 2014; Khoutorsky and Price, 2018; de la Pena et al., 2019) . Importantly, eIF2α phosphorylation, mTORC1 activation and MNK-eIF4E signaling can all lead to persistent sensitization of nociceptors and all of these pathways have been linked to neuropathic pain disorders (Inceoglu et al., 2015; Khoutorsky et al., 2016; Moy et al., 2017; Megat et al., 2019; Shiers et al., 2019) We have tested the hypothesis that type I IFNs generate a pain response via a direct action on nociceptors. We find compelling evidence that exogenous and endogenous type I IFNs produce mechanical hypersensitivity via MNK-eIF4E signaling in nociceptors. This likely occurs as a downstream consequence of canonical JAK signaling. We find no evidence for engagement of PKR-eIF2α signaling in nociceptors by type I IFNs. Our findings provide a mechanistic link between type I IFNs and MNK-eIF4E signaling as a causative factor in pain produced by viral infection.
MATERIALS AND METHODS

Animals
Male eIF4E S209A and MNK1 -/mice were a gift of the Sonenberg laboratory at McGill University (Ueda et al., 2004; Furic et al., 2010) and bred at the University of Texas at Dallas (UTD) to generate experimental animals. Genotype was confirmed at weaning using DNA from ear clips. Experimental C57BL/6J wild-type (WT) animals were obtained from an internally maintained C57BL/6J colony at UTD. Electrophysiological experiments using WT mice were performed using mice between the ages of 4 and 6 weeks at the start of the experiment. Behavioral experiments using eIF4E S209A , MNK1 -/-(knockout for the Mknk1 gene) and WT mice were performed using mice between the ages of 8 and 12 (Becton Dickinson, NJ) . DRG neurons were maintained in a 37˚C incubator containing 5% CO2 with a media change every other day. On day 6, DRG neurons were treated with either vehicle, IFN-α or IFNβ for 1, 3, 6 and 24h. Following treatments, cells were rinsed with chilled 1X PBS buffer, harvested in 200 μL of RIPA lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, pH 8.0, and 1% Triton X-100) containing protease and phosphatase inhibitors (Sigma-Aldrich), and then sonicated for 5 seconds. To clear debris, samples were centrifuged at 14,000 rpm for 15 min at 4˚C. Ten to 15 μg of protein was loaded into each well and separated by a 10% SDS-PAGE gel. Proteins were transferred to a 0.45 PVDF membrane (Millipore, MA) at 30 V overnight at 4˚C. Subsequently, membranes were blocked with 5% non-fat dry milk in 1X Tris buffer solution containing Tween 20 (TTBS) for at least 2 h.
Membranes were washed 3 times for 10 minutes each (3 x 10) in 1X TTBS, then incubated with primary antibodies overnight at 4˚C. The following day, membranes were washed 3 x 10 each then incubated with the corresponding secondary antibodies at room temperature for 1 h. After incubation, membranes were washed with 1X TTBS 3 x 10 each. Signals were detected using Immobilon Western Chemiluminescent HRP Substrate (Millipore) and then visualized with Bio-Rad ChemiDoc Touch.
Membranes were stripped using Restore Western Blot Stripping buffer (Thermo Fisher Scientific) and
reprobed with another antibody. Analysis was performed using Image lab 6.0.1 software for Mac (Bio-Rad, Hercules, CA).
To perform western blot analysis (WB) from tissues, animals were anesthetized with isoflurane and killed by decapitation. Lumbar spinal dorsal horn, L4-L5 DRGs and sciatic nerve were immediately frozen on dry ice and then sonicated for at least 10 seconds in 300 μL of RIPA lysis buffer containing protease and phosphatase inhibitors. To clear debris, samples were centrifuged at 14,000 rpm for 15 min at 4˚C. Samples were processed for WB using the experimental protocol and analysis described above.
Immunofluorescence
For primary neuronal cultures, DRG neurons were harvested and cultured for 6 days according to the protocol described above with the exception that cells were distributed evenly on poly-D-lysine-coated 8-well chamber slide with removable wells (cat # 12-565-8, Fisher Scientific). After treatments, cells were fixed in ice-cold 10% formalin in 1X PBS for 1 h and processed for immunocytochemistry (ICC).
Cells were washed with 1X PBS and permeabilized in 1X PBS containing 10% heat-inactivated normal goat serum (NGS; Atlanta Biologicals, Atlanta, GA) and 0.02% Triton X-100 (Sigma) in 1X PBS for 30 min and then blocked in 10% NGS in 1X PBS for 2 h. Primary antibodies were applied overnight at 4˚C and the next day appropriate secondary antibodies (Alexa Fluor; Invitrogen) were applied for 1 h. After additional 1X PBS washes, coverslips were mounted on Superfrost plus slides with ProLong Gold antifade (Invitrogen). Images were taken using an Olympus FluoView 1200 confocal microscope and analyzed with FIJI for Mac OS X. Images shown are representative of samples taken from 3 separate wells and presented as projections of Z stacks. Using ImageJ, the corrected total cell fluorescence (CTCF) was calculated to determine the intensity of the signal between experimental groups. To do so, the integrated density and the area, as well as the background noise was measured and the CTCF calculated as equal to: the integrated density -(area of selected cell x mean fluorescence of background readings). CTCF values from all experimental treatment groups were normalized to vehicle groups and expressed as normalized CTCF.
For tissues, animals were anesthetized with isoflurane and killed by decapitation, and tissues were frozen in O.C.T. on dry ice. Spinal cords were pressure ejected using chilled 1X PBS. Sections of L4-L5 DRGs (20 μm) were mounted onto SuperFrost Plus slides (Thermo Fisher Scientific) and fixed in icecold 10% formalin in 1X PBS for 1 h then subsequently washed 3 x 10 each in 1X PBS and processed for immunohistochemistry (IHC). Slides were permeabilized in 50% ethanol for 30 min. After 30 min, slides were washed 3 x 10 each in 1X PBS. Tissues were blocked for at least 2 h in 1X PBS and 10% NGS. Primary antibodies against NeuN, peripherin, p-eIF4E S209 and eIF4E were applied and incubated with DRG sections on slides at 4˚C overnight. Immunoreactivity was visualized after 1 h incubation with Alexa Fluor secondary antibodies at room temperature. Images were taken using an Olympus FluoView 1200 confocal microscope. Images are presented as projections of Z stacks, and they are representative of samples taken from 3 animals.
Single cell data
Single cell mouse DRG sequencing data from previously published work (Li et al., 2016) (Butler et al., 2018) was used to cluster the single-cell data and visualization (van der Maaten and Hinton, 2008) .
Patch-clamp electrophysiology
Cell cultures for patch clamp electrophysiology were prepared as previously described (Moy et al., 2017) . Male C57BL/6J mice (average age of 43 days) were anesthetized with 5% isoflurane and sacrificed by decapitation. DRGs were dissected and placed in ice-cold HBSS (divalent free), and incubated at 37°C for 15 min in 20 U/mL Papain (Worthington, Lakewood, NJ) followed by 15 min in 3 mg/ml Collagenase Type II (Worthington). After trituration through a fire-polished Pasteur pipette of progressively smaller opening sizes, cells were plated on poly-D-lysine and laminin (Sigma, St. Louis, MO)-coated plates. Cells were allowed to adhere for several hours at room temperature in a humidified chamber and then nourished with Liebovitz L-15 medium (Life Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS), 10 mM glucose, 10 mM HEPES and 50 U/ml penicillin/streptomycin. The following day (within 24 h of dissociation), changes in neuronal excitability were tested after incubating the neurons with IFN-α (300 U/mL) for 1 h. To do so, whole-cell patchclamp experiments were performed using a MultiClamp 700B (Molecular Devices) patch-clamp amplifier and PClamp 9 acquisition software (Molecular Devices) at room temperature. Recordings were sampled at 20 kHz and filtered at 3 kHz (Digidata 1550B, Molecular Devices). Pipettes (outer diameter, 1.5 mm; inner diameter, 1.1 mm, BF150-110-10, Sutter Instruments) were pulled using a PC-100 puller (Narishige) and heat polished to 3-5 MΩ resistance using a microforge (MF-83, Narishige).
Series resistance was typically 7 MΩ and was compensated up to 60%. Data were analyzed using Clampfit 10 (Molecular Devices). All neurons included in the analysis had a resting membrane potential more negative than -40 mV. The RMP was recorded 1-3 min after achieving whole-cell configuration.
In current-clamp mode, cells were held at -60 mV and action potentials were elicited by injecting slow ramp currents from 100 to 700 pA with Δ 200 pA over 1 s to mimic slow depolarization. Only cells that responded to the ramp depolarization -at least one spike at the maximum 700 pA, were considered for further analysis. The pipette solution contained the following (in mM): 120 K-gluconate, 6 KCl, 4 ATP-Mg, 0.3 GTP-Na, 0.1 EGTA, 10 HEPES and 10 phosphocreatine, pH 7.4 (adjusted with N-methyl glucamine), and osmolarity was ~285 mOsm. The external solution contained the following (in mM):
135 NaCl, 2 CaCl2, 1 MgCl2, 5 KCl, 10 glucose, and 10 HEPES, pH 7.4 (adjusted with N-methyl glucamine), and osmolarity was adjusted to ~315 mOsm with sucrose.
Behavior
Mice were housed on 12-hour light/dark cycles with food and water available ad libitum. Mice were randomized to groups from multiple cages to avoid using mice from experimental groups that were cohabitating. Sample size was estimated by performing a power calculation using G*Power (version 3.1.9.2). With 80% power and an expectation of d = 2.2 effect size in behavioral experiments, and α set to 0.05, the sample size required was calculated as n = 6 per group. We therefore sought to have at least n = 6 sample in all behavioral experiments. SD (set at 0.3) for the power calculation was based on previously published mechanical threshold data from our lab (Moy et al., 2017) . Animals were habituated for 1 hour to clear acrylic behavioral chambers before beginning the experiment. For 
Quantification and statistical analysis
All results are presented as the mean ± SEM. Statistical differences between 2 groups were determined by the Student t test. One-or 2-way analysis of variance, followed by Dunnett or Bonferroni test, was used to compare differences between more than 2 groups. Post-hoc testing for electrophysiology data used Fisher's LSD test. Differences were considered to reach statistical significance when P < 0.05.
Complete statistical analysis is detailed on Data analysis was performed using GraphPad Prism 8.0 (GraphPad Software).
Data and code availability
The data that support the findings of this study, including specific details of how tSNE plots were generated, are available from the corresponding author upon reasonable request.
RESULTS
Characterizing pain behavior responses induced by peripheral administration of type I IFNs
We first sought to investigate the nociceptive responses produced by type I interferons (α and β) in vivo in both sexes. The dose (300 units (U) -approximately 5 ng) of IFNs was chosen based on previous studies showing concentration-dependent effects on cellular signaling pathways (Larner et al., 1986; Hilkens et al., 2003) and studies showing plasma levels of type I IFNs in mice in response to viral infection (~ 1-2 ng/ml) (Gerlach et al., 2006; Shibamiya et al., 2009; Murray et al., 2015; Cheng et al., 2017 
Identifying IFNRs expression in sensory neurons and their downstream signaling pathways
Because we observed a pronociceptive effect of IFN-α and IFN-β, we investigated the expression of IFNRs in DRG neurons. We used mouse DRG deeply RNA sequenced single cell data generated by (Li et al., 2016) . We generated tSNE plots to show genes expression in specific clusters of cells (van der Maaten and Hinton, 2008). IFN-α and IFN-β bind a heterodimeric transmembrane receptor termed the IFN-α receptor (IFNAR), which is composed of IFNAR1 and IFNAR2 subunits (Schreiber, 2017) . We observed expression of both Ifnar1 (Interferon receptor 1, IFNR1) and Ifnar2 (Interferon receptor 2, IFNR2) mRNAs with the neuronal marker rbfox3 (NeuN), indicating their presence in neuronal populations in the mouse DRG ( Figure 2A) . Ifnar2 mRNA appears to be more highly expressed than Ifnar1 mRNA in many cells. Ifnar1 and Ifnar2 mRNAs were co-expressed among neurons that are likely to be nociceptors because they also express Prph (peripherin) and Scn10a (Nav1.8) ( Figure 2B ).
Additionally, we detected that Ifnar1 and Ifnar2 mRNAs are widely distributed across nociceptors of peptidergic [Trpv1 (TRPV1), Calca (CGRP)] and non-peptidergic [P2rx3 (P2X3)] nature ( Figure 2C ).
Ifnar2 mRNA shows higher expression levels than Ifnar1 in neurons containing F2rl1 (PAR2) and Nppb (NPPB) mRNAs ( Figure 2D ). Therefore, IFNRs are present in DRG neurons and their activation could modulate nociceptive signaling events.
We then sought to investigate the downstream signaling events evoked by type I IFN application to cultured DRG neurons. We focused on two major pathways involved in type I IFN signaling in different Figure 2E ). This signaling cascade involved the phosphorylation of JAK1, STAT1 and STAT3 together with a delayed increase in STAT1 total protein, likely representing a transcriptional change. In addition to STATs, other signaling factors have a role in IFN-mediated activities. These include activation of the AKT/mTOR/ULK1 pathway via PI3K and the ERK/MAP kinase pathway (Thyrell et al., 2004; Platanias, 2005; Hjortsberg et al., 2007; Saleiro et al., 2015) . We did not observe any changes in mTOR or ribosomal protein S6 phosphorylation ( Figure 2F ) but we did observe an increase in ERK and eIF4E phosphorylation that occurred rapidly after type 1 IFN exposure ( Figure  2G ). Both IFN-α and IFN-β also stimulated AKT phosphorylation ( Figure 2G ). These findings demonstrate that type I IFNs engage cap-dependent translation regulation signaling via MNK-eIF4E.
Type 1 IFNs are also known to regulate translation via induction of PKR and activation of the integrated stress response (ISR). We did not observe changes in p-PKR or p-eIF2α levels and no changes were observed in BiP expression (ER chaperone protein) in response to type I IFN exposure ( Figure 3A and 3B). Twenty four hr exposure to either IFN-α or IFN-β did not modify PKR phosphorylation or expression suggesting that type 1 IFNs do not induce PKR expression in DRG neurons ( Figure 3C ). In further support of these observations, no changes on p-PKR/PKR after a long IFN-α exposure were observed in the presence of the integrated stress response inhibitor ISRIB ( Figure 3C ), and ISRIB does not suppress signaling pathways shown to be modulated by IFN-α 
Patch-clamp electrophysiology on DRG neurons links Type I IFNs activity to neuron hyperexcitability
To assess whether the effects of type I interferons contribute to nociceptor excitability, we exposed DRG neurons to IFN-α (300 U/mL) for ~1 h (average exposure time: 86.6±7 min) and measured neuronal excitability using patch-clamp electrophysiology. The treatment was present in both the L-15 culture medium and later in the external bath solution until completion of the electrophysiology experiments. Patch clamp electrophysiology was performed from small-and medium-sized populations of neurons in the cultured DRGs in both groups (capacitance: control 23.8 ± 2.9 pF vs IFN-α 24.3 ± 1.5 pF, P = 0.89; diameter: control 26.5 ± 0.56 pF vs IFN-α 26.8 ± 0.53 pF, P = 0.7; Figure 4A ). Resting membrane potential (RMP) was more hyperpolarized than -40 mV in all cells sampled and IFN-α treatment did not alter the RMP compared to the control group (control -51.2 ± 3 mV vs IFN-α -47.5 ± 2.5 mV, P = 0.38; Figure 4A ). In response to ramp current injections mimicking slow depolarizations, DRG neurons exposed to IFN-α showed elevated excitability, measured as the number of action potentials elicited, compared to the control group with a significant main effect of treatment (F (1,48) = 22.9, P < 0.001). Significant differences were observed at each time point of ramp injection tested (Figures 4B and 4C) . We further measured the latency to the first spike following ramp current injection and determined that exposure to IFN-α shortened the latency of initiation of the action potential (F (1,48) = 21.02, P < 0.001; Figure 4D ). Therefore, type I IFN exposure rapidly promotes hyperexcitability in small diameter DRG neurons over a time course coinciding with MNK-eIF4E activation.
MNK-eIF4E signaling links type I IFN actions on sensory neurons to mechanical hypersensitivity
Since we previously observed that ERK/MNK-eIF4E signaling axis was the primary component contributing to IFN-α and IFN-β effects in DRG neurons, we targeted this pathway using genetic tools to investigate its contribution to type 1 IFN-induced pain hypersensitivity. When ERK is activated, it subsequently phosphorylates MNK1/2 (Waskiewicz et al., 1997) leading to phosphorylation of eIF4E at serine 209 (Waskiewicz et al., 1999) . We used immunocytochemistry (ICC) on cultured DRG neurons to assess whether type 1 IFNs impacts eIF4E phosphorylation at single cell resolution. We found that one-hour stimulation with either IFN-α (300 U/mL) or IFN-β (300 U/mL) stimulated phosphorylation of eIF4E mostly in neurons expressing peripherin, a marker for nociceptors ( Figure 5A and 5B). To assess the behavioral impact of this signaling, we used MNK1 -/mice ( Figure 5C ) and tested mechanical hypersensitivity after i.pl. IFN-α (300 U/25 μL) or IFN-β (300 U/25 μL) administration. Mechanical hypersensitivity was attenuated in MNK1 -/mice compared to WT mice following IFN application ( Figures 5D and 5E ). Furthermore, mice lacking eIF4E phosphorylation at serine 209 (eIF4E S209A , Figure 5F ) showed a complete absence of eIF4E phosphorylation in lumbar (L5) DRGs ( Figure 5G ) and a significant reduction in mechanical hypersensitivity following i.pl. IFN injection ( Figures 5H and 5I ).
We conclude that a MNK-eIF4E signaling mechanism strongly contributes to type I IFN-induced pain hypersensitivity. , 2008) . We found that mice injected with poly (I:C) developed mechanical hypersensitivity ( Figure 6A ) as well as thermal hypersensitivity ( Figure 6B ) over a time-course of 3-24 h after the second poly (I:C) administration. Changes in mechanical and thermal hypersensitivity were preceded by an increase in core body temperature, consistent with known physiological effects of poly (I:C) ( Figure 6C ). Based on our previous observations, we hypothesized that the effects seen on thermal and mechanical hypersensitivity would be mechanistically linked to MNK-eIF4E signaling. As predicted, poly (I:C) administration increased phosphorylated eIF4E immunoreactivity in L5 DRGs of WT mice without affecting total eIF4E protein ( Figure 6D ). Mechanical ( Figure 6E ) and thermal (figure 6F) hypersensitivity produced by poly (I:C) was attenuated in MNK1 -/compared to WT mice. Similarly, mechanical ( Figure 6G ) and thermal ( Figure 6H ) hypersensitivity was decreased in eIF4E S209A mice compared to WTs. Moreover, L4-L5 DRGs, lumbar spinal dorsal horn (SDH) and sciatic nerve from MNK1 -/and eIF4E S209A mice showed a decrease and absence, respectively, of eIF4E phosphorylation compared to WT mice following poly (I:C) administration ( Figure   6I ). Finally, we tested whether poly (I:C) had a direct effect on DRG neurons. Direct application of poly (I:C) did not increase p-ERK, p-eIF4E, p-PKR or p-eIF2α in cultured DRG neurons ( Figure 6J ), suggesting that effects observed with poly (I:C) in vivo are unlikely explained by a direct action of the compound on DRG neurons. Instead, poly (I:C) likely acts via endogenous production of type I IFNs that then act on DRG neurons. These experiments demonstrate that endogenous type I IFN production acts via MNK-eIF4E signaling to induce pain hypersensitivity.
Induction of endogenous type I interferon response with poly (I:C) causes MNK-eIF4E
DISCUSSION
Our findings provide evidence for a mechanistic link between viral infection, type 1 IFN production and rapid induction of nociceptor hyperexcitability and mechanical pain sensitization. This occurs via a direct action of type I IFN receptors on sensory neurons and is dependent on downstream signaling via MNK-eIF4E. We find no evidence for mTORC1 activation or induction of eIF2α phosphorylation in DRG neurons by type I IFNs, demonstrating that the key translation regulation pathway engaged is eIF4E phosphorylation. Collectively, these results provide molecular insight into why one of the first signs of viral infection is body-wide aches and pain.
While it is well known that viral infection can cause pain, very little work has been done to understand the underlying mechanisms driving this effect (Chiu et al., 2016) . Aches and pain caused by viral infection have classically been attributed to fever but these aches and pain often begin before the onset of fever. Our findings with poly (I:C) treatment in mice show that fever and pain effects are disassociated, but in this case the fever clearly preceded hyperalgesia caused by poly (I:C) treatment.
An alternative mechanism for viral infection-induced pain is upregulation of IDO1 enzyme and consequent increased production of kynurenine. In support of this idea, mice lacking IDO1 show and prolonged production of type I IFNs can cause neuropathic pain, it is possible that type I IFN receptor signaling to MNK-eIF4E may be a key pathway for production of these types of neuropathies.
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